BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34182184)

  • 21. The Lung Immune Prognostic Index Discriminates Survival Outcomes in Patients with Solid Tumors Treated with Immune Checkpoint Inhibitors.
    Meyers DE; Stukalin I; Vallerand IA; Lewinson RT; Suo A; Dean M; North S; Pabani A; Cheng T; Heng DYC; Bebb DG; Morris DG
    Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic Value of the Lung Immune Prognostic Index for Patients Treated for Metastatic Non-Small Cell Lung Cancer.
    Kazandjian D; Gong Y; Keegan P; Pazdur R; Blumenthal GM
    JAMA Oncol; 2019 Oct; 5(10):1481-1485. PubMed ID: 31343662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer.
    Sonehara K; Tateishi K; Komatsu M; Yamamoto H; Hanaoka M
    Thorac Cancer; 2020 Jun; 11(6):1578-1586. PubMed ID: 32286017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On-treatment lung immune prognostic index is predictive for first-line PD-1 inhibitor combined with chemotherapy in patients with non-small cell lung cancer.
    Xiong A; Xu J; Wang S; Zhong R; Lu J; Chu T; Zhang W; Li Y; Zheng X; Han B; Nie W; Zhong H; Zhang X
    Front Immunol; 2023; 14():1173025. PubMed ID: 37304273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial.
    Hopkins AM; Kichenadasse G; Abuhelwa AY; McKinnon RA; Rowland A; Sorich MJ
    Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33803256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of lung immune prognostic index with survival outcome in advanced thymic carcinoma patients treated with palliative intent chemotherapy.
    Araki T; Tateishi K; Komatsu M; Sonehara K; Kanda S; Hanaoka M; Koizumi T
    Thorac Cancer; 2022 Apr; 13(7):1006-1013. PubMed ID: 35156310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic role of pretreatment lung immune prognostic index in extensive-stage small-cell lung cancer treated with platinum plus etoposide chemotherapy.
    Qi W; Zhao S; Chen J
    Cancer Biomark; 2021; 31(2):177-185. PubMed ID: 33896825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of the Lung Immune Prognostic Index for Metastatic Non-Small Cell Lung Cancer Patients: A Chinese Cohort Study.
    Huang J; Pu H; He J; Tang X
    Int J Gen Med; 2023; 16():881-893. PubMed ID: 36915421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Predictive and Prognostic Importance of Lung Immune Prognostic Index in Locally Advanced Rectal Cancer Patients Treated With Neoadjuvant Chemoradiotherapy.
    Arıkan R; Alkış H; Işık S; Yaşar A; Çelebi A; Majidova N; Sever N; Adlı M; Demircan NC
    Cureus; 2023 Jun; 15(6):e40548. PubMed ID: 37465788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of the Lung Immune Prognostic Index with Immunotherapy Outcomes in Mismatch Repair Deficient Tumors.
    Auclin E; Vuagnat P; Smolenschi C; Taieb J; Adeva J; Nebot-Bral L; Garcia de Herreros M; Vidal Tocino R; Longo-Muñoz F; El Dakdouki Y; Martín-Romano P; Gaba L; Saurí T; Oliveres H; Castañón E; Garcia-Carbonero R; Besse B; Massard C; Mezquita L; Hollebecque A
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359675
    [No Abstract]   [Full Text] [Related]  

  • 31. Three models that predict the efficacy of immunotherapy in Chinese patients with advanced non-small cell lung cancer.
    Zhao Q; Li B; Xu Y; Wang S; Zou B; Yu J; Wang L
    Cancer Med; 2021 Sep; 10(18):6291-6303. PubMed ID: 34390218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of dNLR and LIPI scores on the prognosis of elderly patients with non-surgical treatment of non-small cell lung cancer].
    Xie JH; Liu MM; Sun NN; Zhang L; Zhang HZ
    Zhonghua Zhong Liu Za Zhi; 2022 Sep; 44(9):975-980. PubMed ID: 36164700
    [No Abstract]   [Full Text] [Related]  

  • 33. The Lung Immune Prognostic Index May Predict the Efficacy of Different Treatments in Patients with Advanced NSCLC: A Meta-Analysis.
    Xie J; Zang Y; Liu M; Peng L; Zhang H
    Oncol Res Treat; 2021; 44(4):164-175. PubMed ID: 33657566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of the pretreatment lung immune prognostic index in patients with metastatic hormone-sensitive and castration-resistant prostate cancer.
    Wang Z; Liu H; Zhao J; Chen J; Zhu S; Dai J; Ni Y; Xu N; Zhao F; He B; Zhang X; Liang J; Sun G; Liu Z; Shen P; Zeng H
    Ann Transl Med; 2023 Mar; 11(5):201. PubMed ID: 37007568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors.
    Che H; Xiong Q; Ma J; Chen S; Wu H; Xu H; Hou B
    BMC Cancer; 2022 Aug; 22(1):904. PubMed ID: 35986342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of survival in advanced non-small cell lung cancer patients treated with anti-PD-1/PD-L1 therapy.
    Ali WAS; Hui P; Ma Y; Wu Y; Zhang Y; Chen Y; Hong S; Yang Y; Huang Y; Zhao Y; Fang W; Zhao H; Zhang L
    Ann Transl Med; 2021 Nov; 9(22):1639. PubMed ID: 34988148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of first-line PD-L1/PD-1 inhibitors in limited-stage small cell lung cancer: a multicenter propensity score matched retrospective study.
    Xie J; Xu K; Cai Z; Chen M; Jiang Y; Ye J; Lin X; Lv T; Zhan P
    Transl Lung Cancer Res; 2024 Mar; 13(3):526-539. PubMed ID: 38601454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early Changes in LIPI Score Predict Immune-Related Adverse Events: A Propensity Score Matched Analysis in Advanced Non-Small Cell Lung Cancer Patients on Immune Checkpoint Blockade.
    Nelli F; Fabbri A; Virtuoso A; Giannarelli D; Giron Berrios JR; Marrucci E; Fiore C; Ruggeri EM
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38275894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy.
    Hopkins AM; Wagner J; Kichenadasse G; Modi N; Rowland A; Sorich MJ
    Int J Cancer; 2020 Dec; 147(11):3085-3089. PubMed ID: 32492185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of Immunotherapy Efficacy in Metastatic Non-Small Cell Lung Cancer: Lung Immune Prognostic Index and Immune-Related Toxicity.
    Moratiel Pellitero A; Zapata Garcia M; Gascon Ruiz M; Arbones-Mainar JM; Lastra Del Prado R; Isla D
    World J Oncol; 2024 Apr; 15(2):223-238. PubMed ID: 38545481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.